DaVita Receives Civil Complaint

EL SEGUNDO, Calif., Aug. 31 DaVita Inc.(NYSE: DVA), today announced it received a copy of a civil complaint filed inU.S. District Court for the Central District of California by plaintiff SheetMetal Workers National Health Fund. The complaint names as defendants Amgen,Inc., Fresenius Medical Care Holdings, Inc. and DaVita Inc. The complaint,which has not yet been served on DaVita, is styled as a request for classaction and alleges claims against DaVita relating to the administration anduse of Epogen(R). The complaint's principal allegations against DaVita arethat Epogen(R) was administered to hemodialysis patients intravenously, asopposed to subcutaneously, and that Epogen(R) was over-utilized.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

DaVita administers Epogen(R) only pursuant to a physician's order, and thephysician determines both the dosage amount and route of administration ofEpogen(R). Also, the FDA-approved package insert for Epogen(R) recommends thatEpogen(R) be administered intravenously for patients on hemodialysis. DaVitaintends to vigorously defend the plaintiffs' claims and allegations containedin the complaint.

DaVita is a leading provider of dialysis services for patients sufferingfrom chronic kidney failure. DaVita operates and provides administrativeservices to approximately 1,300 outpatient dialysis centers located in42 states and the District of Columbia, serving approximately104,000 patients.

SOURCE DaVita Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...